Dr. Lucio Gordan Accepts Term on Editorial Board of Journal of Clinical Oncology - Clinical Cancer Informatics

Florida Cancer Specialists’ Gainesville Physician Lends Expertise to Leading Oncology Publication



Gainesville, FL – May 17, 2016……… Florida Cancer Specialists & Research Institute (FCS) is pleased to announce that Dr. Lucio Gordan, who practices at the Gainesville Cancer Center of FCS, has accepted a new term on the Editorial Board of the Journal of Clinical Oncology Clinical Cancer Informatics (JCO CCI). The Journal of Clinical Oncology, published by the American Society of Clinical Oncology (ASCO), is a global journal for disseminating significant clinical oncology research. According to ASCO, the new JCO CCI is an “online-only journal publishing high quality studies representing actionable knowledge, clinical and are delivery research validations and new research hypotheses, based on the growing knowledge base represented by EHR (Electronic Health Records), registry, and clinical trials data to genomics databases.”

Dr. Gordan, who serves on the Executive Board of FCS and as Medical Co-Director of Health Information Technology, said, “I am honored to be asked to serve on the editorial board for Clinical Cancer Informatics. The journal publishes reviews, editorials, and commentaries on data studies relevant to cancer care, as well as papers on the methodology and interpretation of clinical cancer informatics research. This is of critical importance in translating oncology research into new standards for improving patient care.”

FCS CEO Brad Prechtl noted, “Dr. Gordan’s work in this area represents the strong focus we have to help develop better systems and platforms for sharing the rapidly-growing knowledge base in oncology. His selection to the editorial board of this highly-respected journal is a further indication of his exceptional expertise and experience. FCS is extremely proud and appreciative to have his caliber of physician leaders in our organization.”

Dr. William Harwin, Founder and President of FCS, added, “In addition to providing world-class clinical care to our patients, FCS is also committed to clinical trials research, including a Phase 1 Clinical Trials Program that rivals many academic medical centers. Being able to disseminate the data gathered in our clinical research programs is of utmost importance and Dr. Gordan’s selection to the editorial board of JCO CCI puts him on the cutting-edge of this rapidly advancing area of information technology and helping to transform scientific research into new cancer treatments.”